The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for at least 72 hours after the ingestion of a single 150-mg tablet.
Scope of the Report:
This report focuses on the Drugs for Vulvovaginal Candidiasis in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufacturers, countries/Regions, type and application.
Market Segment by Manufacturers, this report covers
Bayer
Perrigo
J & J
Pfizer
Bristol-Myers Squibb
Effik
Teva
Sanofi
Cisen Pharmaceutical
Kingyork Group
Market Segment by Countries, covering
United States
United Kingdom
Canada
Germany
France
Italy
Spain
Market Segment by Type, covers
Miconazole
Clotrimazole
Fluconazole
Econazole
Other
Market Segment by Applications, can be divided into
Hospital & Clinic
Pharmacy
There are 19 Chapters to deeply display the North America and Europe Drugs for Vulvovaginal Candidiasis market.
Chapter 1, to describe Drugs for Vulvovaginal Candidiasis Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Drugs for Vulvovaginal Candidiasis, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the North America and Europe market by countries, covering United States, United Kingdom, Canada, France, Germany, Italy and Spain, with sales, price, revenue and market share of Drugs for Vulvovaginal Candidiasis, for each country, from 2013 to 2018;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;
Chapter 7, 8, 9, 10, 11, 12 and 13 to analyze the key countries by manufacturers, Type and Application, covering 7 countries, with sales, revenue and market share by manufacturers, types and applications;
Chapter 14, Drugs for Vulvovaginal Candidiasis market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2018 to 2023;
Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process, etc.
Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 17, to describe sales channel, distributors, traders, dealers, etc.
Chapter 18 and 19, to describe the research findings and conclusion, appendix, methodology and data source.
Table of Contents
1 Market Overview
1.1 Drugs for Vulvovaginal Candidiasis Introduction
1.2 Market Analysis by Type
1.2.1 Miconazole
1.2.2 Clotrimazole
1.2.3 Fluconazole
1.2.4 Econazole
1.2.5 Other
1.3 Market Analysis by Applications
1.3.1 Hospital & Clinic
1.3.2 Pharmacy
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2013-2023)
1.4.2 Canada Status and Prospect (2013-2023)
1.4.3 United Kingdom Status and Prospect (2013-2023)
1.4.4 Germany Status and Prospect (2013-2023)
1.4.5 France Status and Prospect (2013-2023)
1.4.6 Italy Status and Prospect (2013-2023)
1.4.7 Spain Status and Prospect (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Bayer Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Perrigo
2.2.1 Business Overview
2.2.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Perrigo Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 J & J
2.3.1 Business Overview
2.3.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 J & J Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Pfizer Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bristol-Myers Squibb
2.5.1 Business Overview
2.5.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Effik
2.6.1 Business Overview
2.6.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Effik Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Teva
2.7.1 Business Overview
2.7.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Teva Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Sanofi
2.8.1 Business Overview
2.8.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Sanofi Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Cisen Pharmaceutical
2.9.1 Business Overview
2.9.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Kingyork Group
2.10.1 Business Overview
2.10.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Kingyork Group Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 North America and Europe Drugs for Vulvovaginal Candidiasis Market Competition, by Manufacturer
3.1 North America and Europe Drugs for Vulvovaginal Candidiasis Sales and Market Share by Manufacturer (2016-2017)
3.2 North America and Europe Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Manufacturer (2016-2017)
3.2.1 North America and Europe Drugs for Vulvovaginal Candidiasis Revenue by Manufacturer (2016-2017)
3.2.2 North America and Europe Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer (2016-2017)
3.3 North America and Europe Drugs for Vulvovaginal Candidiasis Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Drugs for Vulvovaginal Candidiasis Manufacturer Market Share (2016-2017)
3.4.2 Top 5 Drugs for Vulvovaginal Candidiasis Manufacturer Market Share (2016-2017)
3.5 Market Competition Trend
4 North America and Europe Drugs for Vulvovaginal Candidiasis Market Analysis by Countries/Regions
4.1 North America and Europe Drugs for Vulvovaginal Candidiasis Sales Market Share by Countries/Regions
4.2 North America and Europe Drugs for Vulvovaginal Candidiasis Sales by Countries/Regions (2013-2018)
4.2.1 North America and Europe Drugs for Vulvovaginal Candidiasis Sales by Countries/Regions (2013-2018)
4.2.2 North America and Europe Drugs for Vulvovaginal Candidiasis Sales Market Share by Countries (2013-2018)
4.3 North America and Europe Drugs for Vulvovaginal Candidiasis Revenue (Value) by Countries (2013-2018)
4.3.1 North America and Europe Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
4.3.2 North America and Europe Drugs for Vulvovaginal Candidiasis Revenue Market Share by Countries (2013-2018)
5 North America and Europe Market Segmentation Drugs for Vulvovaginal Candidiasis by Type
5.1 North America and Europe Drugs for Vulvovaginal Candidiasis Sales, Revenue and Market Share by Type (2013-2018)
5.1.1 North America and Europe Drugs for Vulvovaginal Candidiasis Sales and Market Share by Type (2013-2018)
5.1.2 North America and Europe Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Type (2013-2018)
5.2 Miconazole Sales Growth and Price
5.2.1 North America and Europe Miconazole Sales Growth (2013-2018)
5.2.2 North America and Europe Miconazole Price (2013-2018)
5.3 Clotrimazole Sales Growth and Price
5.3.1 North America and Europe Clotrimazole Sales Growth (2013-2018)
5.3.2 North America and Europe Clotrimazole Price (2013-2018)
5.4 Fluconazole Sales Growth and Price
5.4.1 North America and Europe Fluconazole Sales Growth (2013-2018)
5.5 Econazole Sales Growth and Price
5.5.1 North America and Europe Econazole Sales Growth (2013-2018)
5.5.2 North America and Europe Econazole Price (2013-2018)
5.6 Other Sales Growth and Price
5.6.1 North America and Europe Other Sales Growth (2013-2018)
5.6.2 North America and Europe Other Price (2013-2018)
6 North America and Europe Market Segmentation Drugs for Vulvovaginal Candidiasis by Application
6.1 North America and Europe Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
6.2 Hospital & Clinic Sales Growth (2013-2018)
6.3 Pharmacy Sales Growth (2013-2018)
7 United States Drugs for Vulvovaginal Candidiasis Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Drugs for Vulvovaginal Candidiasis Revenue, Sales and Growth Rate (2013-2018)
7.2 United States Drugs for Vulvovaginal Candidiasis Sales and Market Share by Type (2013-2018)
7.2.1 United States Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
7.2.2 United States Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2013-2018)
7.3 United States Drugs for Vulvovaginal Candidiasis Sales and Market Share by Application (2013-2018)
7.3.1 United States Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
7.3.2 United States Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
7.4 United States Drugs for Vulvovaginal Candidiasis Sales, Revenue and Market Share by Manufacturer (2016-2017)
7.4.1 United States Drugs for Vulvovaginal Candidiasis Sales and Market Share by Manufacturer (2016-2017)
7.4.2 United States Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Manufacturer (2016-2017)
7.5 United States Drugs for Vulvovaginal Candidiasis Export and Import (2013-2018)
8 United Kingdom Drugs for Vulvovaginal Candidiasis Sales, Revenue, by Type, Application and Manufacturers
8.1 United Kingdom Drugs for Vulvovaginal Candidiasis Revenue, Sales and Growth Rate (2013-2018)
8.2 United Kingdom Drugs for Vulvovaginal Candidiasis Sales and Market Share by Type (2016-2017)
8.2.1 United Kingdom Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
8.2.2 United Kingdom Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2013-2018)
8.3 United Kingdom Drugs for Vulvovaginal Candidiasis Sales and Market Share by Application (2013-2018)
8.3.1 United Kingdom Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
8.3.2 United Kingdom Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
8.4 United Kingdom Drugs for Vulvovaginal Candidiasis Sales, Revenue and Market Share by Manufacturer (2016-2017)
8.4.1 United Kingdom Drugs for Vulvovaginal Candidiasis Sales and Market Share by Manufacturer (2016-2017)
8.4.2 United Kingdom Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Manufacturer (2016-2017)
8.5 United Kingdom Drugs for Vulvovaginal Candidiasis Export and Import (2013-2018)
9 Canada Drugs for Vulvovaginal Candidiasis Sales, Revenue, by Type, Application and Manufacturers
9.1 Canada Drugs for Vulvovaginal Candidiasis Revenue, Sales and Growth Rate (2013-2018)
9.2 Canada Drugs for Vulvovaginal Candidiasis Sales and Market Share by Type (2013-2018)
9.2.1 Canada Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
9.2.2 Canada Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2013-2018)
9.3 Canada "&Sheet1!$B$1&" Sales and Market Share by Application (2013-2018)"
9.3.1 Canada Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
9.3.2 Canada Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
9.4 Canada Drugs for Vulvovaginal Candidiasis Sales, Revenue and Market Share by Manufacturer (2016-2017)
9.4.1 Canada Drugs for Vulvovaginal Candidiasis Sales and Market Share by Manufacturer (2016-2017)
9.4.2 Canada Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Manufacturer (2016-2017)
9.5 Canada Drugs for Vulvovaginal Candidiasis Export and Import (2013-2018)
10 Germany Drugs for Vulvovaginal Candidiasis Sales, Revenue, by Type, Application and Manufacturers
10.1 Germany Drugs for Vulvovaginal Candidiasis Revenue, Sales and Growth Rate (2013-2018)
10.2 Germany Drugs for Vulvovaginal Candidiasis Sales and Market Share by Type (2013-2018)
10.2.1 Germany Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
10.2.2 Germany Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2013-2018)
10.3 Germany Drugs for Vulvovaginal Candidiasis Sales and Market Share by Application (2013-2018)
10.3.1 Germany Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
10.3.2 Germany Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
10.4 Germany Drugs for Vulvovaginal Candidiasis Sales, Revenue and Market Share by Manufacturer (2016-2017)
10.4.1 Germany Drugs for Vulvovaginal Candidiasis Sales and Market Share by Manufacturer (2016-2017)
10.4.2 Germany Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Manufacturer (2016-2017)
10.5 Germany Drugs for Vulvovaginal Candidiasis Export and Import (2013-2018)
11 France Drugs for Vulvovaginal Candidiasis Sales, Revenue, by Type, Application and Manufacturers
11.1 France Drugs for Vulvovaginal Candidiasis Revenue, Sales and Growth Rate (2013-2018)
11.2 France Drugs for Vulvovaginal Candidiasis Sales and Market Share by Type (2013-2018)
11.2.1 France Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
11.2.2 France Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2013-2018)
11.3 France "&Sheet1!$B$1&" Sales by Application (2013-2018)"
11.3.1 France Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
11.3.2 France Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
11.4 France Drugs for Vulvovaginal Candidiasis Sales, Revenue and Market Share by Manufacturer (2016-2017)
11.4.1 France Drugs for Vulvovaginal Candidiasis Sales and Market Share by Manufacturer (2016-2017)
11.4.2 France Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Manufacturer
11.5 France Drugs for Vulvovaginal Candidiasis Export and Import (2013-2018)
12 Italy Drugs for Vulvovaginal Candidiasis Sales, Revenue, by Type, Application and Manufacturers
12.1 Italy Drugs for Vulvovaginal Candidiasis Revenue, Sales and Growth Rate (2013-2018)
12.2 Italy Drugs for Vulvovaginal Candidiasis Sales and Market Share by Type (2013-2018)
12.2.1 Italy Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
12.2.2 Italy Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2013-2018)
12.3 Italy Drugs for Vulvovaginal Candidiasis Sales and Market Share by Application (2013-2018)
12.3.1 Italy Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
12.3.2 Italy Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
12.4 Italy Drugs for Vulvovaginal Candidiasis Sales, Revenue and Market Share by Manufacturer (2016-2017)
12.4.1 Italy Drugs for Vulvovaginal Candidiasis Sales and Market Share by Manufacturer (2016-2017)
12.4.2 Italy Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Manufacturer (2016-2017)
12.5 Italy Drugs for Vulvovaginal Candidiasis Export and Import (2013-2018)
13 Spain Drugs for Vulvovaginal Candidiasis Sales, Revenue, by Type, Application and Manufacturers
13.1 Spain Drugs for Vulvovaginal Candidiasis Revenue, Sales and Growth Rate (2013-2018)
13.2 Spain Drugs for Vulvovaginal Candidiasis Sales and Market Share by Type (2013-2018)
13.2.1 Spain Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
13.2.2 Spain Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2013-2018)
13.3 Spain Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
13.3.1 Spain Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
13.3.2 Spain Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
13.4 Spain Drugs for Vulvovaginal Candidiasis Sales, Revenue and Market Share by Manufacturer (2016-2017)
13.4.1 Spain Drugs for Vulvovaginal Candidiasis Sales and Market Share by Manufacturer (2016-2017)
13.4.2 Spain Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Manufacturer (2016-2017)
13.5 Spain Drugs for Vulvovaginal Candidiasis Export and Import (2013-2018)
14 Drugs for Vulvovaginal Candidiasis Market Forecast (2018-2023)
14.1 North America and Europe Drugs for Vulvovaginal Candidiasis Sales, Revenue and Growth Rate (2018-2023)
14.2 Drugs for Vulvovaginal Candidiasis Market Forecast by Countries/Regions (2018-2023)
14.2.1 United States Drugs for Vulvovaginal Candidiasis Sales and Growth Rate Forecast (2018-2023)
14.2.2 United Kingdom Drugs for Vulvovaginal Candidiasis Sales and Growth Rate Forecast (2018-2023)
14.2.3 Canada Drugs for Vulvovaginal Candidiasis Sales and Growth Rate Forecast (2018-2023)
14.2.4 Germany Drugs for Vulvovaginal Candidiasis Sales and Growth Rate Forecast (2018-2023)
14.2.5 France Drugs for Vulvovaginal Candidiasis Sales and Growth Rate Forecast (2018-2023)
14.2.6 Italy Drugs for Vulvovaginal Candidiasis Sales and Growth Rate Forecast (2018-2023)
14.2.7 Spain Drugs for Vulvovaginal Candidiasis Sales and Growth Rate Forecast (2018-2023)
14.3 Drugs for Vulvovaginal Candidiasis Market Forecast by Type (2018-2023)
14.3.1 North America and Europe Drugs for Vulvovaginal Candidiasis Sales Forecast by Type (2018-2023)
14.3.2 North America and Europe Drugs for Vulvovaginal Candidiasis Market Share Forecast by Type (2018-2023)
14.4 Drugs for Vulvovaginal Candidiasis Market Forecast by Application (2018-2023)
14.4.1 North America and Europe Drugs for Vulvovaginal Candidiasis Sales Forecast by Application (2018-2023)
14.4.2 North America and Europe Drugs for Vulvovaginal Candidiasis Market Share Forecast by Application (2018-2023)
15 Drugs for Vulvovaginal Candidiasis Manufacturing Cost Analysis
15.1 Drugs for Vulvovaginal Candidiasis Key Raw Materials Analysis
15.1.1 Key Raw Materials
15.1.2 Price Trend of Key Raw Materials
15.1.3 Key Suppliers of Raw Materials
15.1.4 Market Concentration Rate of Raw Materials
15.2 Proportion of Manufacturing Cost Structure
15.2.1 Raw Materials
15.2.2 Labor Cost
15.2.3 Manufacturing Expenses
15.3 Manufacturing Process Analysis of Drugs for Vulvovaginal Candidiasis
16 Industrial Chain, Sourcing Strategy and Downstream Buyers
16.1 Drugs for Vulvovaginal Candidiasis Industrial Chain Analysis
16.2 Upstream Raw Materials Sourcing
16.3 Raw Materials Sources of Drugs for Vulvovaginal Candidiasis Major Manufacturers in 2017
16.4 Downstream Buyers
17 Sales Channel, Distributors, Traders and Dealers
17.1 Sales Channel
17.1.1 Direct Marketing
17.1.2 Indirect Marketing
17.1.3 Marketing Channel Future Trend
17.2 Distributors, Traders and Dealers
18 Research Findings and Conclusion
19 Appendix
19.1 Methodology
19.2 Data Source
List of Tables and Figures
Figure Drugs for Vulvovaginal Candidiasis Picture
Table Product Specifications of Drugs for Vulvovaginal Candidiasis
Figure North America and Europe Sales Market Share of Drugs for Vulvovaginal Candidiasis by Types in 2017
Table Types of Drugs for Vulvovaginal Candidiasis
Figure Miconazole Picture
Figure Clotrimazole Picture
Figure Fluconazole Picture
Figure Econazole Picture
Figure Other Picture
Figure North America and Europe Drugs for Vulvovaginal Candidiasis Sales Market Share by Applications in 2017
Table Applications of Drugs for Vulvovaginal Candidiasis
Figure Hospital & Clinic Picture
Figure Pharmacy Picture
Figure United States Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2023)
Figure Canada Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2023)
Figure United Kingdom Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2023)
Figure Germany Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2023)
Figure France Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2023)
Figure Italy Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2023)
Figure Spain Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2023)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Drugs for Vulvovaginal Candidiasis Type and Applications
Table Bayer Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Perrigo Basic Information, Manufacturing Base and Competitors
Table Perrigo Drugs for Vulvovaginal Candidiasis Type and Applications
Table Perrigo Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table J & J Basic Information, Manufacturing Base and Competitors
Table J & J Drugs for Vulvovaginal Candidiasis Type and Applications
Table J & J Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Drugs for Vulvovaginal Candidiasis Type and Applications
Table Pfizer Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Type and Applications
Table Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Effik Basic Information, Manufacturing Base and Competitors
Table Effik Drugs for Vulvovaginal Candidiasis Type and Applications
Table Effik Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Drugs for Vulvovaginal Candidiasis Type and Applications
Table Teva Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Drugs for Vulvovaginal Candidiasis Type and Applications
Table Sanofi Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cisen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Type and Applications
Table Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kingyork Group Basic Information, Manufacturing Base and Competitors
Table Kingyork Group Drugs for Vulvovaginal Candidiasis Type and Applications
Table Kingyork Group Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America and Europe Drugs for Vulvovaginal Candidiasis Sales by Manufacturer (2016-2017)
Figure North America and Europe Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2016
Figure North America and Europe Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2017
Table North America and Europe Drugs for Vulvovaginal Candidiasis Revenue by Manufacturer (2016-2017)
Table North America and Europe Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer (2016-2017)
Figure North America and Europe Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2016
Figure North America and Europe Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2017
Table North America and Europe Drugs for Vulvovaginal Candidiasis Price by Manufacturers (2016-2017)
Figure Top 3 Drugs for Vulvovaginal Candidiasis Manufacturer Market Share in 2016
Figure Top 3 Drugs for Vulvovaginal Candidiasis Manufacturer Market Share in 2017
Figure Top 5 Drugs for Vulvovaginal Candidiasis Manufacturer Market Share in 2016
Figure Top 5 Drugs for Vulvovaginal Candidiasis Manufacturer Market Share in 2017
Figure North America and Europe Drugs for Vulvovaginal Candidiasis Sales and Growth (2013-2018)
Table North America and Europe Drugs for Vulvovaginal Candidiasis Sales by Countries/Regions (2013-2018)
Table North America and Europe Drugs for Vulvovaginal Candidiasis Sales Market Share by Countries (2013-2018)
Figure North America and Europe Drugs for Vulvovaginal Candidiasis Sales Market Share by Countries in 2013
Figure North America and Europe Drugs for Vulvovaginal Candidiasis Sales Market Share by Countries in 2017
Figure North America and Europe Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
Table North America and Europe Drugs for Vulvovaginal Candidiasis Revenue by Countries (2013-2018)
Table North America and Europe Drugs for Vulvovaginal Candidiasis Revenue Market Share by Countries (2013-2018)
Figure North America and Europe Drugs for Vulvovaginal Candidiasis Revenue Market Share by Countries in 2013
Figure North America and Europe Drugs for Vulvovaginal Candidiasis Revenue Market Share by Countries in 2017
Table North America and Europe Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
Table North America and Europe Drugs for Vulvovaginal Candidiasis Sales Share by Type (2013-2018)
Table North America and Europe Drugs for Vulvovaginal Candidiasis Revenue by Type (2013-2018)
Table North America and Europe Drugs for Vulvovaginal Candidiasis Revenue Share by Type (2013-2018)
Figure North America and Europe Miconazole Sales Growth (2013-2018)
Figure North America and Europe Miconazole Price (2013-2018)
Figure North America and Europe Clotrimazole Sales Growth (2013-2018)
Figure North America and Europe Clotrimazole Price (2013-2018)
Figure North America and Europe Fluconazole Sales Growth (2013-2018)
Figure North America and Europe Fluconazole Price (2013-2018)
Figure North America and Europe Econazole Sales Growth (2013-2018)
Figure North America and Europe Econazole Price (2013-2018)
Figure North America and Europe Other Sales Growth (2013-2018)
Figure North America and Europe Other Price (2013-2018)
Table North America and Europe Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
Table North America and Europe Drugs for Vulvovaginal Candidiasis Sales Share by Application (2013-2018)
Figure North America and Europe Hospital & Clinic Sales Growth (2013-2018)
Figure North America and Europe Pharmacy Sales Growth (2013-2018)
Figure United States Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
Figure United States Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Table United States Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
Table United States Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2013-2018)
Table United States Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
Table United States Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
Table United States Drugs for Vulvovaginal Candidiasis Sales by Manufacturer (2016-2017)
Figure United States Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2016
Figure United States Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2017
Table United States Drugs for Vulvovaginal Candidiasis Revenue by Manufacturer (2016-2017)
Figure United States Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2016
Figure United States Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2017
Table United States Drugs for Vulvovaginal Candidiasis Export and Import (2013-2018)
Figure United Kingdom Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
Figure United Kingdom Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Table United Kingdom Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
Table United Kingdom Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2013-2018)
Table United Kingdom Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
Table United Kingdom Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
Table United Kingdom Drugs for Vulvovaginal Candidiasis Sales by Manufacturer (2016-2017)
Figure United Kingdom Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2016
Figure United Kingdom Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2017
Table United Kingdom Drugs for Vulvovaginal Candidiasis Revenue by Manufacturer (2016-2017)
Figure United Kingdom Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2016
Figure United Kingdom Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2017
Table United Kingdom Drugs for Vulvovaginal Candidiasis Export and Import (2013-2018)
Figure Canada Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
Figure Canada Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Table Canada Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
Table Canada Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2013-2018)
Table Canada Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
Table Canada Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
Table Canada Drugs for Vulvovaginal Candidiasis Sales by Manufacturer (2016-2017)
Figure Canada Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2016
Figure Canada Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2017
Table Canada Drugs for Vulvovaginal Candidiasis Revenue by Manufacturer (2016-2017)
Figure Canada Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2016
Figure Canada Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2017
Table Canada Drugs for Vulvovaginal Candidiasis Export and Import (2013-2018)
Figure Germany Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
Figure Germany Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Table Germany Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
Table Germany Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2013-2018)
Table Germany Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
Table Germany Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
Table Germany Drugs for Vulvovaginal Candidiasis Sales by Manufacturer (2016-2017)
Figure Germany Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2016
Figure Germany Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2017
Table Germany Drugs for Vulvovaginal Candidiasis Revenue by Manufacturer (2016-2017)
Figure Germany Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2016
Figure Germany Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2017
Table Germany Drugs for Vulvovaginal Candidiasis Export and Import (2013-2018)
Figure France Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
Figure France Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Table France Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
Table France Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2013-2018)
Table France Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
Table France Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
Table France Drugs for Vulvovaginal Candidiasis Sales by Manufacturer (2016-2017)
Figure France Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2016
Figure France Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2017
Table France Drugs for Vulvovaginal Candidiasis Revenue by Manufacturer (2016-2017)
Figure France Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2016
Figure France Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2017
Table France Drugs for Vulvovaginal Candidiasis Export and Import (2013-2018)
Figure Italy Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
Figure Italy Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Table Italy Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
Table Italy Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2013-2018)
Table Italy Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
Table Italy Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
Table Italy Drugs for Vulvovaginal Candidiasis Sales by Manufacturer (2016-2017)
Figure Italy Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2016
Figure Italy Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2017
Table Italy Drugs for Vulvovaginal Candidiasis Revenue by Manufacturer (2016-2017)
Figure Italy Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2016
Figure Italy Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2017
Table Italy Drugs for Vulvovaginal Candidiasis Export and Import (2013-2018)
Figure Spain Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
Figure Spain Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Table Spain Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
Table Spain Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2013-2018)
Table Spain Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
Table Spain Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
Table Spain Drugs for Vulvovaginal Candidiasis Sales by Manufacturer (2016-2017)
Figure Spain Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2016
Figure Spain Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2017
Table Spain Drugs for Vulvovaginal Candidiasis Revenue by Manufacturer (2016-2017)
Figure Spain Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2016
Figure Spain Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2017
Table Spain Drugs for Vulvovaginal Candidiasis Export and Import (2013-2018)
Figure North America and Europe Drugs for Vulvovaginal Candidiasis Sales, Revenue and Growth Rate (2018-2023)
Table North America and Europe Drugs for Vulvovaginal Candidiasis Sales Forecast by Countries/Regions (2018-2023)
Table North America and Europe Drugs for Vulvovaginal Candidiasis Market Share Forecast by Countries/Regions (2018-2023)
Figure United States Drugs for Vulvovaginal Candidiasis Sales and Growth Rate Forecast (2018-2023)
Figure United Kingdom Drugs for Vulvovaginal Candidiasis Sales and Growth Rate Forecast (2018-2023)
Figure Canada Drugs for Vulvovaginal Candidiasis Sales and Growth Rate Forecast (2018-2023)
Figure Germany Drugs for Vulvovaginal Candidiasis Sales and Growth Rate Forecast (2018-2023)
Figure France Drugs for Vulvovaginal Candidiasis Sales and Growth Rate Forecast (2018-2023)
Figure Italy Drugs for Vulvovaginal Candidiasis Sales and Growth Rate Forecast (2018-2023)
Figure Spain Drugs for Vulvovaginal Candidiasis Sales and Growth Rate Forecast (2018-2023)
Table North America and Europe Drugs for Vulvovaginal Candidiasis Sales Forecast by Type (2018-2023)
Table North America and Europe Drugs for Vulvovaginal Candidiasis Market Share Forecast by Type (2018-2023)
Table North America and Europe Drugs for Vulvovaginal Candidiasis Sales Forecast by Application (2018-2023)
Table North America and Europe Drugs for Vulvovaginal Candidiasis Market Share Forecast by Application (2018-2023)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Vulvovaginal Candidiasis
Figure Manufacturing Process Analysis of Drugs for Vulvovaginal Candidiasis
Figure Drugs for Vulvovaginal Candidiasis Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Vulvovaginal Candidiasis Major Manufacturers in 2017
Table Major Buyers of Drugs for Vulvovaginal Candidiasis
Table Distributors/Traders/ Dealers List
